The most common alterations in driver genes are KRAS mutations (4-24%), with a much less frequency of EGFR, ALK, RET, and absence of others driver mutations associated with NSCLC, such as BRAF and ROS1 (9, 34, 39, 46). This evidence concerns the gene KRAS and non-small cell lung carcinoma.